All News
Dead Words Eulogy
The trouble with rheumatology may be the words we live by. Welcome to the eulogy for rheumatology 'dead words'. We're here today to celebrate the loss of rheumatology past. These are dead words in rheumatology, words fortified unfortunately by history and habit. The lexicon of rheumatology is unique, it's challenging and it's mostly incomprehensible to those who don't know...but those are the cornerstones of the greatest of medical subspecialties.
Read Article
Anti-Drug Antibodies and Biologic Drug Responses
A prospective cohort study suggests the presence of antidrug antibodies may be associated with bDMARDs nonresponse in rheumatoid arthritis (RA). Should we be monitoring ADAbs (especially in nonresponders)?
Read Article
Prevalence of Cardiovascular Disease in Rheumatoid Arthritis
A prospective study of the BioSTAR registry estimates the prevalence of cardiovascular disease in rheumatoid arthritis (RA) to be 4.6%.
Read Article
Check out some of the "newer" modalities available to us for evaluation of our rheumatology patients to better understand their cardiac risk. "Everything has changed in cardiac rheumatology." Dr. B. Weber #RNL2024 @RheumNow https://t.co/fki73W4Fk8
Dr. Rachel Tate uptoTate ( View Tweet)
Dr. B Weber discusses new CV Imaging Tools beyond the exercise EKG and ECHO to assess our rheum patients who are at higher risk for CV disease: coronary CT, Stress CMR, stress PET #RNL2024 @RheumNow https://t.co/DAuUptHMuF
TheDaoIndex KDAO2011 ( View Tweet)
Dr. Brittany Weber showcases the diverse manifestations that we can see in rheumatology and the increasing complexity and use of imaging in field. #RNL2024 @RheumNow https://t.co/0dOJdPazXL
Dr. Rachel Tate uptoTate ( View Tweet)
Ready to get your #GameOn at #RNL2024 @RheumNow https://t.co/joP1xcU0TH
Dr. Rachel Tate uptoTate ( View Tweet)
Starting now - #RNL2024 w @RichardPAConway @RheumNow
Today's Pods: RA - nutrition! prevention!
PsA -@AlexisOgdie on guidelines! Gender differences JAKs -@JointMD and Kevin Winthrop on use and safety SLE - @andreafava on biomarkers
Plus @BharatKumarMD on appreciative rheum
Eric Dein ericdeinmd ( View Tweet)
#RNL2024 has started- not too late to register:
https://t.co/esqYcqSvbP
@RheumNow and Dr A Kavanaugh https://t.co/d6EQFI9rTT
TheDaoIndex KDAO2011 ( View Tweet)
Starting now - #RNL24 w @RichardPAConway
@RheumNow
Today's Pods: RA - nutrition! prevention!
PsA -@AlexisOgdie on guidelines! Gender differences JAKs - @JointMD and Kevin Winthrop on use and safety SLE - @andreafava on biomarkers
Plus @BharatKumarMD on appreciative rheum
Eric Dein ericdeinmd ( View Tweet)
We’re prepping for your arrival! Can’t make it in person? There’s still time to register and attend virtually! https://t.co/2dcFVgu8z6 https://t.co/Yk8FNxuEIm
Links:
Dr. John Cush RheumNow ( View Tweet)
We are so excited for #RNL2024 tomorrow! Will you be attending?
It's not too late to join virtually. We hope you can make it!
https://t.co/Zkev3KMI3K https://t.co/E5LzuPuHFy
Links:
Dr. John Cush RheumNow ( View Tweet)
#RNL2024 Preview! Our Spondyloarthitis Spectrum pod features Drs. Eric Ruderman, Lihi Eder and Lianne Gensler.
There's still time to register: https://t.co/Qc7rdBfDV0 https://t.co/2tYfxkQfdO
Links:
Dr. John Cush RheumNow ( View Tweet)
#RNL2024 Speaker Preview!
Be sure to check out our Vasculitis Mavens this weekend! Drs. Catherine Sims, Anisha Dua, and Philip Seo will be leading exciting talks.
https://t.co/inDKp0JsFu https://t.co/L32LqWrvUM
Links:
Dr. John Cush RheumNow ( View Tweet)
QD Clinics - Sponsored By https://t.co/4UQlqwujiR
Check out our recent QD clinics in one spot!
https://t.co/WcPt6bzEXM https://t.co/EIWuKq4CjN
Dr. John Cush RheumNow ( View Tweet)
Best Treatments for COVID-Related MIS-C
https://t.co/6Ntdug1eam https://t.co/x6de0DQTZ9
Dr. John Cush RheumNow ( View Tweet)
Norweigian nationwide study shows males with inflamm Jt. Dz (IJD) have more children and are less likely to be childless compared with matched controls. Males w/ IJD may be reassured that no impairment of fertility is expected https://t.co/PPv8vnkd0m https://t.co/ZepV4ZEfVn
Dr. John Cush RheumNow ( View Tweet)
16% of patients with nr-axSpA progressed to r-axSpA within 5 years. Male sex, fulfillment of the imaging arm of the ASAS criteria, and good response to nonsteroidal anti-inflammatory drugs were predictors of radiographic progression https://t.co/eargDLHUZ2 https://t.co/xG52uMmYK8
Dr. John Cush RheumNow ( View Tweet)
Study of 235 newly Dx #RA patients (157 females) found that 11 pts (5%) had carpal tunnel syndrom (CTS) at the time of initial RA diagnosis. Such pts were more likey to be older, female, CCP negative and have a longer Sx duration. https://t.co/0CfF0lKBgk https://t.co/tx9CvQ4TWX
Dr. John Cush RheumNow ( View Tweet)
No evidence of harm starting urate lowering Tx (ULT) during #gout attack. Metanalysis 6 RCTs (445 pts) w/ gout attacks given ULT vs PBO or delayed ULT. No differences in pain, time to resolve gout flare or risk of recurrent gout flare in 30d (RR 1.06) https://t.co/xUX2U6MmGP https://t.co/2bV0g2FOSK
Dr. John Cush RheumNow ( View Tweet)